[与新型冠状病毒肺炎相关的脑静脉血栓形成]
[Cerebral venous thrombosis associated with COVID-19].
作者信息
Safina D R, Gismatullina E I, Esin R G
机构信息
Kazan (Volga region) Federal University, Kazan, Russia.
Kazan State Medical Academy, Kazan, Russia.
出版信息
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(9):128-131. doi: 10.17116/jnevro2022122091128.
The literature reports that cerebral venous thrombosis (CVT) develops in 1-1.5% of patients with COVID-19. Recently, a new syndrome named vaccine-induced immune thrombotic thrombocytopenia (VITT) has been described. VITT is a rare side-effect of COVID-19 vaccination that also causes CVT. The article presents an overview of the above problem and a clinical case of a patient with CVT that developed within a month after the first component of the Sputnik V vaccination and COVID-19.
文献报道，1%-1.5%的新冠肺炎患者会发生脑静脉血栓形成（CVT）。最近，一种名为疫苗诱导的免疫性血栓性血小板减少症（VITT）的新综合征被描述出来。VITT是新冠肺炎疫苗接种的一种罕见副作用，也会导致CVT。本文介绍了上述问题的概述以及一例在接种卫星V疫苗第一针和感染新冠肺炎后一个月内发生CVT的患者的临床病例。
Zotero 插件